Kinetics of somatostatin inhibition of pentagastrin-stimualted gastric acid secretion. 1979

G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman

Dogs with gastric fistulae and denervated gastric pouches received graded doses of pentagastrin with and without a background infusion of somatostatin (1 microgram kg-1 h-1). Similarly, graded doses of somatostatin (0.25, 0.5, 1, 2 and 4 microgram kg-1 h-1) were infused after a steady state gastric secretion had been achieved with pentagastrin (1.5 microgram kg-1 h-1), about twice the dose required to produce half maximal (D50) response. Somatostatin inhibited pentagastrin-stimulated gastric acid secretion with competitive inhibition kinetics, but its precise site of action remains uncertain. The minimum effective dose of somatostatin on a twice D50 dose of pentagastrin was 0.25 microgram kg-1 h-1.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005750 Gastric Juice The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651) Gastric Juices,Juice, Gastric,Juices, Gastric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
December 1980, Regulatory peptides,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
May 1975, Deutsche medizinische Wochenschrift (1946),
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
January 1978, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
December 1977, Agents and actions,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
April 1972, The Journal of physiology,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
August 1983, The American journal of physiology,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
September 1978, Metabolism: clinical and experimental,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
July 1982, International journal of clinical pharmacology, therapy, and toxicology,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
February 1986, Gut,
G O Barbezat, and E R Kaplan, and F S Bowey, and M Berelowitz, and R Van Hoorn-Hickman
September 1984, Scandinavian journal of gastroenterology,
Copied contents to your clipboard!